A detailed history of Natixis transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Natixis holds 401,541 shares of GILD stock, worth $37.3 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
401,541
Previous 330,772 21.4%
Holding current value
$37.3 Million
Previous $22.7 Million 48.31%
% of portfolio
0.19%
Previous 0.13%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$66.59 - $83.99 $4.71 Million - $5.94 Million
70,769 Added 21.4%
401,541 $33.7 Million
Q2 2024

Aug 13, 2024

BUY
$63.15 - $72.88 $11.3 Million - $13 Million
178,546 Added 117.29%
330,772 $22.7 Million
Q1 2024

May 13, 2024

BUY
$71.58 - $87.29 $3.14 Million - $3.83 Million
43,916 Added 40.55%
152,226 $11.2 Million
Q4 2023

Feb 13, 2024

SELL
$73.27 - $83.09 $18.1 Million - $20.5 Million
-246,955 Reduced 69.51%
108,310 $8.77 Million
Q3 2023

Nov 14, 2023

SELL
$73.94 - $80.67 $18.4 Million - $20.1 Million
-248,800 Reduced 41.19%
355,265 $26.6 Million
Q2 2023

Aug 11, 2023

SELL
$76.01 - $86.7 $5.02 Million - $5.73 Million
-66,061 Reduced 9.86%
604,065 $46.6 Million
Q1 2023

May 12, 2023

BUY
$77.31 - $88.08 $12.4 Million - $14.1 Million
160,471 Added 31.49%
670,126 $55.6 Million
Q4 2022

Feb 24, 2023

SELL
$62.32 - $89.47 $20.7 Million - $29.7 Million
-331,918 Reduced 39.44%
509,655 $43.8 Million
Q4 2022

Feb 13, 2023

SELL
$62.32 - $89.47 $13.5 Million - $19.4 Million
-217,222 Reduced 20.52%
841,573 $72.2 Million
Q3 2022

Nov 14, 2022

BUY
$59.54 - $68.01 $12.8 Million - $14.6 Million
214,375 Added 25.39%
1,058,795 $65.5 Million
Q2 2022

Aug 12, 2022

SELL
$57.72 - $65.01 $81.4 Million - $91.6 Million
-1,409,680 Reduced 62.54%
844,420 $52.2 Million
Q1 2022

May 13, 2022

BUY
$57.92 - $72.58 $107 Million - $134 Million
1,853,000 Added 461.98%
2,254,100 $134 Million
Q4 2021

Feb 14, 2022

BUY
$64.88 - $73.64 $10.7 Million - $12.2 Million
165,655 Added 70.36%
401,100 $29.1 Million
Q3 2021

Nov 12, 2021

SELL
$67.69 - $73.03 $85.5 Million - $92.3 Million
-1,263,396 Reduced 84.29%
235,445 $16.4 Million
Q2 2021

Aug 13, 2021

BUY
$63.47 - $69.35 $29 Million - $31.7 Million
457,272 Added 43.9%
1,498,841 $103 Million
Q1 2021

May 14, 2021

SELL
$60.0 - $68.46 $17.5 Million - $19.9 Million
-290,971 Reduced 21.84%
1,041,569 $67.3 Million
Q4 2020

Feb 12, 2021

BUY
$56.65 - $64.55 $21.9 Million - $24.9 Million
386,057 Added 40.79%
1,332,540 $77.6 Million
Q3 2020

Nov 12, 2020

BUY
$62.1 - $78.08 $39.6 Million - $49.8 Million
637,447 Added 206.27%
946,483 $59.8 Million
Q2 2020

Aug 13, 2020

BUY
$72.34 - $84.0 $20.7 Million - $24.1 Million
286,749 Added 1286.62%
309,036 $23.8 Million
Q1 2020

May 14, 2020

SELL
$62.63 - $80.22 $119 Million - $152 Million
-1,899,295 Reduced 98.84%
22,287 $1.67 Million
Q4 2019

Feb 14, 2020

BUY
$61.62 - $67.78 $71.2 Million - $78.3 Million
1,155,273 Added 150.76%
1,921,582 $125 Million
Q3 2019

Nov 13, 2019

BUY
$62.51 - $69.0 $25 Million - $27.6 Million
399,942 Added 109.16%
766,309 $48.6 Million
Q2 2019

Aug 13, 2019

SELL
$61.87 - $69.38 $6.71 Million - $7.52 Million
-108,459 Reduced 22.84%
366,367 $24.8 Million
Q1 2019

May 15, 2019

SELL
$62.53 - $70.05 $10.8 Million - $12.1 Million
-172,331 Reduced 26.63%
474,826 $30.2 Million
Q4 2018

Feb 14, 2019

SELL
$60.54 - $79.0 $132 Million - $172 Million
-2,178,597 Reduced 77.1%
647,157 $40.5 Million
Q3 2018

Nov 14, 2018

BUY
$71.28 - $78.92 $65 Million - $72 Million
912,219 Added 47.67%
2,825,754 $218 Million
Q2 2018

Aug 14, 2018

BUY
$64.88 - $75.68 $121 Million - $142 Million
1,872,389 Added 4550.6%
1,913,535 $136 Million
Q1 2018

May 15, 2018

SELL
$72.84 - $88.8 $20 Million - $24.4 Million
-275,059 Reduced 86.99%
41,146 $3.1 Million
Q4 2017

Feb 14, 2018

SELL
$71.15 - $83.52 $144 Million - $169 Million
-2,021,485 Reduced 86.47%
316,205 $22.7 Million
Q3 2017

Nov 14, 2017

BUY
$72.11 - $85.47 $115 Million - $137 Million
1,598,343 Added 216.18%
2,337,690 $189 Million
Q2 2017

Aug 14, 2017

BUY
N/A
739,347
739,347 $52.3 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Natixis Portfolio

Follow Natixis and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.